Your browser doesn't support javascript.
loading
Robust immune responses to SARS-CoV-2 in a pediatric patient with B-Cell ALL receiving tisagenlecleucel.
Gordon, Oren M; Terpilowski, Madeline; Dulman, Robin; Keller, Michael D; Burbelo, Peter D; Cohen, Jeffrey I; Bollard, Catherine M; Dave, Hema.
Afiliação
  • Gordon OM; Department of Pediatrics, Children's National Hospital, Washington, DC, USA.
  • Terpilowski M; Center for Cancer and Immunology Research, Children's Research Institute, Children's National Hospital, Washington, DC, USA.
  • Dulman R; Pediatric Specialists of Virginia, Department of Pediatric Hematology and Oncology, Fairfax, VA, USA.
  • Keller MD; Department of Pediatrics, Children's National Hospital, Washington, DC, USA.
  • Burbelo PD; Center for Cancer and Immunology Research, Children's Research Institute, Children's National Hospital, Washington, DC, USA.
  • Cohen JI; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.
  • Bollard CM; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Dave H; Department of Pediatrics, Children's National Hospital, Washington, DC, USA.
Pediatr Hematol Oncol ; 39(6): 571-579, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35135442
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / COVID-19 Limite: Child / Humans Idioma: En Revista: Pediatr Hematol Oncol Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Receptores de Antígenos Quiméricos / COVID-19 Limite: Child / Humans Idioma: En Revista: Pediatr Hematol Oncol Ano de publicação: 2022 Tipo de documento: Article